BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11408941)

  • 21. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
    Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
    Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).
    Almenara J; Rosato R; Grant S
    Leukemia; 2002 Jul; 16(7):1331-43. PubMed ID: 12094258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An intact NF-kappaB pathway is required for histone deacetylase inhibitor-induced G1 arrest and maturation in U937 human myeloid leukemia cells.
    Dai Y; Rahmani M; Grant S
    Cell Cycle; 2003; 2(5):467-72. PubMed ID: 12963846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cyclin-dependent kinase inhibitor p21(CIP1/WAF1) blocks paclitaxel-induced G2M arrest and attenuates mitochondrial injury and apoptosis in p53-null human leukemia cells.
    Ahmed W; Rahmani M; Dent P; Grant S
    Cell Cycle; 2004 Oct; 3(10):1305-11. PubMed ID: 15467449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage.
    Bissonnette N; Hunting DJ
    Oncogene; 1998 Jul; 16(26):3461-9. PubMed ID: 9692554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.
    DiGiuseppe JA; Kastan MB; Weng LJ; Gore SD
    In Vivo; 1999; 13(1):1-6. PubMed ID: 10218124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol.
    Gao N; Dai Y; Rahmani M; Dent P; Grant S
    Mol Pharmacol; 2004 Oct; 66(4):956-63. PubMed ID: 15235103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p21Waf1/Cip1 acts in synergy with bcl-2 to confer multidrug resistance in a camptothecin-selected human lung-cancer cell line.
    Zhang Y; Fujita N; Tsuruo T
    Int J Cancer; 1999 Dec; 83(6):790-7. PubMed ID: 10597196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of anergy in Th1 cells associated with increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1.
    Jackson SK; DeLoose A; Gilbert KM
    J Immunol; 2001 Jan; 166(2):952-8. PubMed ID: 11145672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcitonin receptor-mediated growth suppression of HEK-293 cells is accompanied by induction of p21WAF1/CIP1 and G2/M arrest.
    Evdokiou A; Raggatt LJ; Atkins GJ; Findlay DM
    Mol Endocrinol; 1999 Oct; 13(10):1738-50. PubMed ID: 10517675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phenol butyrate inhibits cell cycle of leukemia cell lines through up-regulation of p21WAF1/CIP1 gene].
    Wei H; Liu XR; Lin D; Rao Q; Lin YH; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):294-7. PubMed ID: 16875574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells.
    Naujokat C; Sezer O; Zinke H; Leclere A; Hauptmann S; Possinger K
    Eur J Haematol; 2000 Oct; 65(4):221-36. PubMed ID: 11073163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type I interferon induction of the Cdk-inhibitor p21WAF1 is accompanied by ordered G1 arrest, differentiation and apoptosis of the Daudi B-cell line.
    Subramaniam PS; Cruz PE; Hobeika AC; Johnson HM
    Oncogene; 1998 Apr; 16(14):1885-90. PubMed ID: 9583686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53.
    Vrana JA; Decker RH; Johnson CR; Wang Z; Jarvis WD; Richon VM; Ehinger M; Fisher PB; Grant S
    Oncogene; 1999 Nov; 18(50):7016-25. PubMed ID: 10597302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
    Fang L; Igarashi M; Leung J; Sugrue MM; Lee SW; Aaronson SA
    Oncogene; 1999 May; 18(18):2789-97. PubMed ID: 10362249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
    Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
    J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
    Vrana JA; Saunders AM; Chellappan SP; Grant S
    Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells.
    Rosato RR; Almenara JA; Maggio SC; Atadja P; Craig R; Vrana J; Dent P; Grant S
    Mol Cancer Ther; 2005 Nov; 4(11):1772-85. PubMed ID: 16275999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.